Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Chinook Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 155
- +4 vs. Q3 2022
- Shares held
- 58.8M
- +1.37M (+2.4%) vs. Q3 2022
- Total value
- $1.52B
- +$398.5M (+35.5%) vs. Q3 2022
- New holders
- 22
- 58 more added
- Sold out
- 18
- 46 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 149,600 | $3.92M | 0.06% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 151,985 | $3.98M | 0.00% | −164,846−52.0% | Reduced |
| Rafferty Asset Management, LLC | 174,011 | $4.56M | 0.04% | +30,893+21.6% | Added |
| Integral Health Asset Management, LLC | 175,000 | $4.58M | 1.03% | +175,000 | New |
| Bank of America Corp | 175,023 | $4.59M | 0.00% | +35,910+25.8% | Added |
| Renaissance Technologies LLC | 181,662 | $4.76M | 0.01% | −37,680−17.2% | Reduced |
| Putnam Investments LLC | 183,343 | $4.80M | 0.01% | −7,200−3.8% | Reduced |
| Invesco Ltd. | 208,532 | $5.46M | 0.00% | +13,422+6.9% | Added |
| Goldman Sachs Group Inc | 212,176 | $5.56M | 0.00% | −190,414−47.3% | Reduced |
| Bank of New York Mellon Corp | 221,059 | $5.79M | 0.00% | +10,567+5.0% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 235,816 | $6.18M | 0.04% | −51,468−17.9% | Reduced |
| Two Sigma Advisers, LP | 236,980 | $6.21M | 0.02% | −8,200−3.3% | Reduced |
| Saturn V Capital Management LLC | 423,177 | $6.73M | 5.58% | +423,177 | New |
| Morgan Stanley | 282,011 | $7.39M | 0.00% | −3,447−1.2% | Reduced |
| FMR LLC | 306,810 | $8.04M | 0.00% | −22,429−6.8% | Reduced |
| Erste Asset Management GmbH | 307,769 | $8.06M | 0.17% | 00.0% | Unchanged |
| International Biotechnology Trust PLC | 340,389 | $8.91M | 2.75% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 359,785 | $9.43M | 0.02% | −119,742−25.0% | Reduced |
| Ensign Peak Advisors, Inc | 361,838 | $9.48M | 0.02% | +124,933+52.7% | Added |
| Eventide Asset Management, LLC | 368,811 | $9.66M | 0.19% | +368,811 | New |
| Charles Schwab Investment Management Inc | 383,712 | $10.1M | 0.00% | +9,225+2.5% | Added |
| Altium Capital Management LP | 385,000 | $10.1M | 5.16% | −140,000−26.7% | Reduced |
| Millennium Management LLC | 440,738 | $11.5M | 0.01% | +41,769+10.5% | Added |
| Baillie Gifford & Co | 489,708 | $12.8M | 0.01% | +25,394+5.5% | Added |
| Rock Springs Capital Management LP | 507,512 | $13.3M | 0.32% | 00.0% | Unchanged |
| Citadel Advisors LLC | 511,167 | $13.4M | 0.02% | +290,148+131.3% | Added |
| Northern Trust Corp | 533,812 | $14.0M | 0.00% | +111,777+26.5% | Added |
| Nicholas Investment Partners, LP | 642,720 | $16.8M | 1.48% | +75,305+13.3% | Added |
| EcoR1 Capital, LLC | 690,000 | $18.1M | 0.55% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 916,765 | $18.4M | 0.01% | −44,493−4.6% | Reduced |
| Rubric Capital Management LP | 719,809 | $18.9M | 0.83% | −229,357−24.2% | Reduced |
| Driehaus Capital Management LLC | 772,700 | $20.2M | 0.30% | −108,984−12.4% | Reduced |
| Sofinnova Investments, Inc. | 806,459 | $21.1M | 1.28% | +518,558+180.1% | Added |
| Affinity Asset Advisors, LLC | 818,035 | $21.4M | 9.82% | +4,037+0.5% | Added |
| Adage Capital Partners GP, L.L.C. | 820,178 | $21.5M | 0.05% | +720,178+720.2% | Added |
| Laurion Capital Management LP | 829,750 | $21.7M | 0.61% | +643+0.1% | Added |
| Vivo Capital, LLC | 872,151 | $22.9M | 2.77% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 888,249 | $23.3M | 0.10% | −543,145−37.9% | Reduced |
| Federated Hermes, Inc. | 888,454 | $23.3M | 0.06% | +750,191+542.6% | Added |
| Geode Capital Management, LLC | 914,226 | $24.0M | 0.00% | +39,669+4.5% | Added |
| Candriam Luxembourg S.C.A. | 926,155 | $24.3M | 0.16% | +55,000+6.3% | Added |
| Victory Capital Management Inc | 1,163,245 | $30.5M | 0.04% | +136,182+13.3% | Added |
| Pictet Asset Management SA | 1,166,164 | $30.6M | 0.04% | +484,052+71.0% | Added |
| Dimensional Fund Advisors LP | 1,238,080 | $32.4M | 0.01% | +124,336+11.2% | Added |
| Point72 Asset Management, L.P. | 1,267,660 | $33.2M | 0.13% | −1,173,094−48.1% | Reduced |
| Suvretta Capital Management, LLC | 1,444,830 | $37.9M | 1.59% | +54,830+3.9% | Added |
| OrbiMed Advisors LLC | 2,029,300 | $53.2M | 1.02% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,534,102 | $66.4M | 0.40% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 2,551,703 | $66.9M | 10.41% | 00.0% | Unchanged |
| State Street Corp | 2,658,956 | $69.7M | 0.00% | +193,237+7.8% | Added |
| Vanguard Group Inc | 2,792,574 | $73.2M | 0.00% | +392,808+16.4% | Added |
| Deep Track Capital, LP | 3,000,000 | $78.6M | 3.43% | 00.0% | Unchanged |
| BlackRock Inc. | 3,954,741 | $103.6M | 0.00% | +303,442+8.3% | Added |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113.9M | 7.08% | +80,000+1.9% | Added |
| Samsara BioCapital, LLC | 5,161,888 | $135.2M | 29.12% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −95,000−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −58,881−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −30,910−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −27,998−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −23,783−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −23,670−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −15,925−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,193−100.0% | Sold out |
| StepStone Group LP | 0 | $0 | 0.00% | −9,277−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −7,421−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −7,258−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −6,008−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −84−100.0% | Sold out |